Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
L. Serrone
Observed name:
L Serrone
Institutions:
Ospedale G.B. Morgagni - L.Pierantoni,
Azienda Ospedale - Università Padova,
Instituto Nazionale Tumori Regina Elena
Observed institutions:
Ospedale G.B. Morgagni - L.Pierantoni,
Azienda Ospedale - Università Padova,
Instituto Nazionale Tumori Regina Elena
OpenAlex ID:
A5081136844
Dacarbazine-based chemotherapy for metastatic melanoma: thirty-year experience overview.
2000
·
L Serrone
, M Zeuli
, et al.
·
PubMed
·
348
The chemoresistance of human malignant melanoma
1999
·
L. Serrone
, P. Hersey
·
Melanoma Research
·
139
A phase II study of dose-intense ifosfamide plus epirubicin with hematopoietic growth factors for the treatment of patients with advanced soft tissue sarcomas; a novel sequential schedule
2001
·
L. Serrone
, M. Zeuli
, et al.
·
Cancer Chemotherapy and Pharmacology
·
13
13-cis retinoic acid and interferon alfa-2a in the treatment of metastatic renal cell carcinoma.
1998
·
A Casali
, F M Sega
, et al.
·
PubMed
·
7
Ifosfamide and Epirubicin Combination in Untreated Sarcomas: Two Treatment Schedules
2001
·
L. Serrone
, M. Zeuli
, et al.
·
Oncology Research and Treatment
·
5
861 Treatment of advanced soft tissue sarcomas (STS) with high dose epirubicin (HD-EPI)
1995
·
M. Lopez
, L. Serrone
, et al.
·
European Journal of Cancer
·
3
Radiotherapy followed by temozolomide in the treatment of patients with melanoma metastatic to the brain: An Italian multicentre study
2004
·
L. Serrone
, A. Freschi
, et al.
·
Journal of Clinical Oncology
·
2
Salvage chemotherapy for advanced sarcoma patients: a single-institution experience survey.
2002
·
L Serrone
, C Nardoni
, et al.
·
PubMed
Band 24, Heft 5, Oktober 2001
2001
·
G. Hartung
, R.-D. Hofheinz
, et al.
·
Oncology Research and Treatment
PDF
Industrial Forum · Industrieforum
2001
·
G. Hartung
, R.-D. Hofheinz
, et al.
·
Oncology Research and Treatment
PDF
Show more works
View as search
Works count:
10
Citation count:
517
H-index:
5
I10-index:
3
Year
Topic
Type